FDA approves pain pill that combines Tylenol and naproxen
Key Points:
- The FDA approved a new over-the-counter pain relief tablet combining 650 mg of Tylenol (acetaminophen) and 220 mg of naproxen sodium, effective July 24, for adults and children aged 12 and older.
- This non-opioid combination offers up to 12 hours of pain relief and targets different pain mechanisms: Tylenol reduces pain signals quickly, while naproxen addresses inflammation-related pain.
- The combination has been tested in eight clinical studies and showed superior pain relief compared to either medication alone.
- Kenvue, Tylenol's parent company, plans to make the tablet available without a prescription at major retailers soon.
- Despite past controversies involving Tylenol and pregnancy, medical experts continue to endorse acetaminophen as a safe pain and fever treatment during pregnancy.